Calamus--prohibited

Calamus refers to flavoring extracts derived from the rhizome (underground stem) of Acorus calamus, commonly known as sweet flag or calamus root. The plant has been used in traditional medicine and food flavoring for centuries across various cultures. The flavor compound in calamus is primarily composed of volatile oils that produce a warm, slightly bitter, spicy taste profile. However, calamus rhizomes contain beta-asarone and other potentially harmful constituents that led to regulatory restrictions.

Historically, calamus flavoring was used in alcoholic beverages, particularly certain liqueurs and bitters, as well as in some traditional beverages and food preparations. Prior to prohibition, small quantities were incorporated into confectionery and flavoring formulations. The warm, aromatic quality made it popular in folk beverages and traditional remedies, though its use in commercial food production was always limited compared to other natural flavorings.

The primary safety concern with calamus relates to beta-asarone (also called alpha-asarone), a constituent found in certain varieties of Acorus calamus. Animal studies have raised concerns about potential mutagenic and carcinogenic properties of beta-asarone. Research in laboratory animals has suggested potential liver and kidney toxicity at high doses. The concentration of beta-asarone varies significantly depending on the geographic origin and variety of the plant material, with some sources containing higher levels than others. These variations in composition and the inability to establish safe consumption levels contributed to regulatory decisions to restrict its use.

Calamus has been prohibited as a food additive in the United States by the FDA. The prohibition stems from safety concerns rather than lack of efficacy. The European Food Safety Authority (EFSA) and most other major regulatory bodies have similarly restricted or prohibited calamus use in food and beverages. Canada and Australia also maintain restrictions on calamus as a food ingredient. The FDA's prohibition reflects the precautionary approach taken when adequate safety data cannot establish a safe level of consumption. This restriction applies to direct food use, though some jurisdictions may permit its use in certain contexts or allow it only in non-food applications like cosmetics or traditional herbal preparations with appropriate labeling.

Toxicological research conducted in the 1970s and subsequent decades examined the safety profile of calamus and its constituents. Studies published in toxicology journals documented beta-asarone's effects in animal models, showing evidence of potential genotoxicity and concerns about long-term exposure. The variation in beta-asarone content across different calamus varieties was documented in phytochemical literature, demonstrating that some plant sources contain substantially higher levels than others. Literature reviews by regulatory bodies, including those by the FDA and EFSA, synthesized available evidence and concluded that safe consumption levels could not be reliably established given the variability of plant material composition and the toxicological findings. The inability to standardize the ingredient to safe levels of beta-asarone was a key factor in regulatory decisions.